Basket | Login | Register

 
 
 
 

Public attitudes about diagnosis

Value of Knowing

Most report they would see doctor for diagnosis if they had symptoms

People were asked about whether they would see a doctor to get a diagnosis if they were exhibiting symptoms possibly associated with Alzheimer’s. More than eight in ten adults (from 85% in Poland to 95% in Spain) say that if they were exhibiting confusion and memory loss, they would go to a doctor to determine if the cause of the symptoms was Alzheimer’s disease.

Wanting to see a doctor

The survey also found that most would want to be told if they had the disease (question only asked in European countries).

Wanting to know

Also, most repondents would want a family member to see a doctor, if they had symptoms.

Wanting family member to see doctor

The survey also found that most respondents would want the family member to be told, if they had the disease (question only asked in European countries).

Wanting family member to know

Significant public interest in pre-symptomatic testing

The survey asked people about whether they would want to take a medical test, if one became available in the future, which would tell them before they had symptoms if they would get Alzheimer’s disease. The survey
found considerable public interest in such a test. About three in ten (from 23% in Germany to 39% in Spain) say they would be “very likely” to get a test for early diagnosis.

Predictive testing

 

 
 

Last Updated: Wednesday 13 July 2011

 

 
  • Acknowledgements

    The Value of Knowing Survey was designed and analysed by the Harvard School of Public Health and Alzheimer Europe, in collaboration with the following national Alzheimer associations: Alzheimer's Association (US), CEAFA (Spain), Deutsche Alzheimer Gesellschaft (Germany), France Alzheimer (France) and the Polish Alzheimer's Association (Poland). The survey was supported by a grant to Alzheimer Europe from Bayer AG. Bayer was not involved in the design of the survey or the analysis of the findings.
  • CEAFA
  • Deutsche Alzheimer Gesellschaft
  • France Alzheimer
  • Polish Alzheimer's Association
  • Bayer
 
 

Options

  • Send this page to a friend